−72.902MUSD
958KUSD
7.59M
About Oncocyte Corporation
Sector
Industry
CEO
Joshua Riggs
Website
Headquarters
Irvine
Employees (FY)
76
Founded
2009
ISIN
US68235C2061
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
